Results overview: Found 4 records in 0.01 seconds.
Articles, 4 records found
Articles 4 records found  
1.
16 p, 1.9 MB Bespoken Nanoceria : An Effective Treatment in Experimental Hepatocellular Carcinoma / Fernández-Varo, Guillermo (Universitat de Barcelona) ; Perramón, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Carvajal, Silvia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Oró, Denise (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Casals, Eudald (Wuyi University) ; Boix, Loreto (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Oller, Laura (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Macías-Muñoz, Laura (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Marfà, Santi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Casals, Gregori (Working Group for the Biochemical Assessment of Hepatic Disease-SEQC ML) ; Morales-Ruiz, Manuel (Working Group for the Biochemical Assessment of Hepatic Disease-SEQC ML) ; Casado, Pedro (Barts Cancer Institute (BCI)) ; Cutillas, Pedro R. (Barts Cancer Institute (BCI)) ; Bruix, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Navasa, Miquel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Fuster, Josep (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Garcia-Valdecasas, Juan Carlos (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Pavel, Mihai C. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Puntes, Víctor (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Jiménez, Wladimiro (Universitat de Barcelona) ; Universitat Autònoma de Barcelona
Despite the availability of new-generation drugs, hepatocellular carcinoma (HCC) is still the third most frequent cause of cancer-related deaths worldwide. Cerium oxide nanoparticles (CeONPs) have emerged as an antioxidant agent in experimental liver disease because of their antioxidant, anti-inflammatory, and antisteatotic properties. [...]
2020 - 10.1002/hep.31139
Hepatology, Vol. 72 (october 2020) , p. 1267-1282  
2.
22 p, 4.3 MB Cerium oxide nanoparticles protect against oxidant injury and interfere with oxidative mediated kinase signaling in human-derived hepatocytes / Carvajal, Silvia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Perramón, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Casals, Gregori (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Oró, Denise (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ribera, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Morales Ruiz, Manuel (Universitat de Barcelona. Departament de Biomedicina) ; Casals, Eudald (Wuyi University. School of Biotechnology and Health Sciences) ; Casado, Pedro (Queen Mary University of London) ; Melgar Lesmes, Pedro (Universitat de Barcelona. Departament de Biomedicina) ; Fernández-Varo, Guillermo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cutillas, Pedro (Queen Mary University of London) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia) ; Jiménez, Wladimiro (Universitat de Barcelona. Departament de Biomedicina)
Cerium oxide nanoparticles (CeO NPs) possess powerful antioxidant properties, thus emerging as a potential therapeutic tool in non-alcoholic fatty liver disease (NAFLD) progression, which is characterized by a high presence of reactive oxygen species (ROS). [...]
2019 - 10.3390/ijms20235959
International journal of molecular sciences, Vol. 20, Issue 23 (December 2019) , art. 5959  
3.
12 p, 4.4 MB Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats / Córdoba Jover, Bernat (Hospital Clínic i Provincial de Barcelona) ; Arce Cerezo, Altamira (Hospital Clínic i Provincial de Barcelona) ; Ribera, Jordi (Hospital Clínic i Provincial de Barcelona) ; Pauta, Montse (Hospital Clínic i Provincial de Barcelona) ; Oró, Denise (Hospital Clínic i Provincial de Barcelona) ; Casals, Gregori (Hospital Clínic i Provincial de Barcelona) ; Fernández-Varo, Guillermo (Hospital Clínic i Provincial de Barcelona) ; Casals, Eudald (Institut Català de Nanociència i Nanotecnologia) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia) ; Jiménez, Wladimiro (Universitat de Barcelona. Departament de Biomedicina) ; Morales Ruiz, Manuel (Universitat de Barcelona. Departament de Biomedicina)
Background and aims: Cerium oxide nanoparticles are effective scavengers of reactive oxygen species and have been proposed as a treatment for oxidative stress-related diseases. Consequently, we aimed to investigate the effect of these nanoparticles on hepatic regeneration after liver injury by partial hepatectomy and acetaminophen overdose. [...]
2019 - 10.1186/s12951-019-0544-5
Journal of nanobiotechnology, Vol. 17 (October 2019) , art. 112  
4.
20 p, 2.6 MB Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease / Carvajal, Silvia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Perramón, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Oró, Denise (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Casals, Eudald (Wuyi University. School of Biotechnology and Health Sciences) ; Fernández-Varo, Guillermo (Universitat de Barcelona. Departament de Biomedicina) ; Parra-Robert, Marina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; González de la Presa, Bernardino. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ribera, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Pastor, Óscar (Hospital Universitario Ramón y Cajal (Madrid)) ; Morales Ruiz, Manuel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia) ; Jiménez, Wladimiro (Universitat de Barcelona. Departament de Biomedicina)
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, ranging from steatosis to non-alcoholic steatohepatitis (NASH). Recently, cerium oxide nanoparticles (CeO₂NPs) have emerged as a new antioxidant agent with hepatoprotective properties in experimental liver disease. [...]
2019 - 10.1038/s41598-019-49262-2
Scientific reports (Nature Publishing Group), Vol. 9 (2019) , art. 12848  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.